Iranian Journal of Pharmaceutical Research

Scope & Guideline

Connecting scholars to elevate the standards of drug research.

Introduction

Immerse yourself in the scholarly insights of Iranian Journal of Pharmaceutical Research with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1735-0328
PublisherBRIEFLAND
Support Open AccessNo
CountryIran
TypeJournal
Convergefrom 2002 to 2024
AbbreviationIRAN J PHARM RES / Iran. J. Pharm. Res.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address25 Derde Morgen , Shertogenbosch 5233 NL, NETHERLANDS

Aims and Scopes

The Iranian Journal of Pharmaceutical Research focuses on advancing the field of pharmaceutical sciences through research and innovation. The journal encompasses a broad range of topics related to drug discovery, development, and clinical applications, while promoting methodologies that enhance pharmaceutical research and practice.
  1. Pharmaceutical Chemistry:
    Research in this area includes the design, synthesis, and characterization of novel pharmaceutical compounds, focusing on their potential therapeutic effects and mechanisms of action.
  2. Drug Delivery Systems:
    The journal publishes studies on innovative drug delivery mechanisms, including nanotechnology, liposomes, and microemulsions, aimed at improving the efficacy and safety of pharmaceuticals.
  3. Pharmacogenomics and Personalized Medicine:
    Research focusing on the genetic factors that influence drug response, including the development of pharmacogenomic strategies to optimize drug therapy for individuals.
  4. Clinical Trials and Pharmacotherapy:
    The journal includes reports on clinical trials assessing the safety and efficacy of various therapeutic agents, along with studies evaluating treatment protocols for diverse diseases.
  5. Natural Products and Ethnopharmacology:
    This scope includes the investigation of plant-derived compounds and traditional medicines, exploring their pharmacological properties and potential therapeutic applications.
  6. Toxicology and Safety Assessment:
    Research in this area assesses the safety profiles of drugs and pharmaceutical products, including studies on adverse effects, toxicity mechanisms, and risk assessments.
  7. Biotechnology and Molecular Pharmacology:
    Studies focusing on biopharmaceuticals, including the use of genetic engineering and molecular biology techniques to develop novel therapeutic agents.
The Iranian Journal of Pharmaceutical Research has recently seen a rise in publications focusing on cutting-edge areas of pharmaceutical science, reflecting contemporary challenges and advancements in the field.
  1. Nanomedicine and Nanotechnology:
    There is a growing emphasis on the use of nanotechnology in drug delivery systems, with studies exploring the efficacy of nanoparticles and nanocarriers in enhancing therapeutic outcomes.
  2. Bioinformatics and Computational Drug Design:
    Emerging research is increasingly incorporating bioinformatics tools for drug discovery, including molecular docking studies and predictive modeling, highlighting the integration of computational methods in pharmaceutical research.
  3. Immunotherapy and Biologics:
    Research focusing on immunotherapeutics and biological agents is on the rise, reflecting a broader trend towards biologics in treating various diseases, including cancer and autoimmune disorders.
  4. Pharmaceutical Biotechnology:
    The journal is witnessing an increase in studies related to the development of biopharmaceuticals, including monoclonal antibodies and gene therapies, indicating a shift towards advanced therapeutic modalities.
  5. Sustainable and Green Chemistry in Pharmaceuticals:
    There is an emerging interest in environmentally friendly practices in pharmaceutical research, such as green synthesis methods and sustainable drug development, reflecting global trends towards sustainability.

Declining or Waning

In recent years, certain research areas within the Iranian Journal of Pharmaceutical Research have shown a decline in publication frequency. This may reflect shifting priorities in pharmaceutical research or broader trends in the field.
  1. Traditional Medicine Studies:
    While previously a significant focus, there has been a noticeable decrease in publications related to traditional medicinal practices and their pharmacological validation, possibly due to a shift towards more evidence-based pharmaceutical research.
  2. Basic Pharmaceutical Sciences:
    Research purely focused on the fundamental aspects of pharmaceutical sciences, such as pharmacokinetics and pharmacodynamics, appears to be less frequently published, indicating a trend towards more applied and clinical research.
  3. Regulatory Affairs and Policy Studies:
    There has been a decrease in articles addressing pharmaceutical regulations and policies, possibly due to the increasing emphasis on practical applications and clinical outcomes in current research.

Similar Journals

Journal of Research in Pharmacy

Exploring New Horizons in Pharmacy and Toxicology
Publisher: MARMARA UNIVISSN: 2630-6344Frequency: 4 issues/year

Journal of Research in Pharmacy, published by Marmara University, serves as a pivotal platform for the dissemination of innovative research in the field of pharmacology and pharmaceutical sciences. With an ISSN of 2630-6344 and an E-ISSN of the same, this journal is dedicated to publishing high-quality research spanning various aspects of pharmacology, toxicology, and pharmaceutics. The journal, categorized in Q3 for both pharmacology (medical) and miscellaneous pharmacology, toxicology, and pharmaceutics in 2023, showcases the ongoing evolution of these disciplines amid growing scientific inquiry. As of now, it ranks #56/80 in general pharmacology, toxicology and pharmaceutics, spotlighting its relevance within the academic community. Although it operates under a traditional access model, the journal is committed to providing researchers, professionals, and students with a comprehensive understanding of contemporary challenges and innovations in pharmacy research. Established in 2019, it continues to foster academic dialogue and contribute significantly to the advancement of pharmacological sciences until at least 2024. For all interested in cutting-edge pharmaceutical research, this journal presents an invaluable resource from its base in Istanbul, Turkey.

Journal of Pharmacology & Pharmacotherapeutics

Illuminating the Future of Pharmacology and Patient Care
Publisher: SAGE PUBLICATIONS INCISSN: 0976-500XFrequency: 4 issues/year

Journal of Pharmacology & Pharmacotherapeutics is a vital academic resource published by SAGE Publications Inc., focusing on the diverse and evolving fields of pharmacology and pharmacotherapy. With an ISSN of 0976-500X and E-ISSN 0976-5018, this journal serves as a platform for rigorous research and innovative insights from 2010 to 2024, reflecting the latest advancements and challenges within the pharmacological landscape. Despite being placed in the Q4 quartile for both general pharmacology and medical pharmacology in 2023, it continues to be an essential resource for researchers, professionals, and students striving to understand the complexities of drug action, therapy optimization, and pharmaceutical sciences. The journal underscores the importance of disseminating critical findings to stimulate further research and collaborative dialogue. Although currently not open access, it can be accessed through leading academic databases, positioning itself as a significant entity in the medical and pharmacological research community.

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

Innovating the future of pharmacology and toxicology.
Publisher: PHARMACEUTICAL SOC JAPANISSN: 0031-6903Frequency: 12 issues/year

YAKUGAKU ZASSHI - JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, published by the Pharmaceutical Society of Japan, is a key academic journal dedicated to advancing the field of pharmaceutical sciences. Established in 1961 and set to contribute until 2024, this journal publishes original research articles, reviews, and clinical studies that encompass a wide spectrum of topics within pharmacology, toxicology, and pharmaceutics. Although the journal operates under a traditional subscription model, it maintains a recognized reputation with an impact factor that is steadily aligned within its category quartiles—ranking Q3 in Pharmaceutical Science and Q4 in Pharmacology as of 2023. With Scopus rankings reflecting its competitive standing, YAKUGAKU ZASSHI serves as a vital resource for researchers, professionals, and students looking to engage with innovative findings and broaden their understanding of pharmaceutical methodologies and research practices. With a current focus on bridging scientific research with real-world applications, it seeks to foster collaboration and knowledge sharing within the pharmaceutical community.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Unveiling Innovations in Drug Action and Therapeutics
Publisher: SPRINGERISSN: 0028-1298Frequency: 12 issues/year

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is a prestigious journal published by SPRINGER, focusing on the dynamic fields of pharmacology and toxicology. With an ISSN of 0028-1298 and an E-ISSN of 1432-1912, this esteemed publication has been a staple in the scientific community since its inception in 1969, continuing to wield influence with a convergence of research that reaches through 2024. Ranked in the Q2 category for both medicine and pharmacology, it stands at an impressive 111th out of 313 in the Scopus rankings for pharmacology, reflecting its significant impact in the field. Though not offering open access, the journal remains a vital resource for researchers, professionals, and students seeking to explore groundbreaking studies and advancements in pharmacological science. With its high standards and comprehensive coverage, NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is essential reading for those dedicated to understanding the mechanisms of drug action and the complexities of therapeutic interventions.

Advances in Pharmacological and Pharmaceutical Sciences

Exploring Innovations in Pharmaceutical Research.
Publisher: HINDAWI LTDISSN: 2633-4682Frequency: 1 issue/year

Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.

BIOLOGICAL & PHARMACEUTICAL BULLETIN

Unlocking New Horizons in Pharmaceutical Research
Publisher: PHARMACEUTICAL SOC JAPANISSN: 0918-6158Frequency: 12 issues/year

BIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.

Pharmaceutical Sciences

Pioneering research at the intersection of science and health.
Publisher: TABRIZ UNIV MEDICAL SCIENCES, FAC PHARMACYISSN: 1735-403XFrequency: 4 issues/year

Pharmaceutical Sciences, an esteemed journal published by Tabriz University of Medical Sciences, Faculty of Pharmacy, serves as a crucial platform for the dissemination of pioneering research in the fields of pharmaceutical science, pharmacology, and toxicology. With an impact factor reflective of its substantial contribution to the scientific community, this open access journal has been accessible since 2012, ensuring that researchers, professionals, and students worldwide can engage with its rich content. Located in Iran, it has continually evolved, covering research from 2009 to 2024, and boasts impressive rankings in multiple Scopus categories, including Q3 in Pharmaceutical Science and Q2 in Pharmacology, Toxicology and Pharmaceutics. By bridging gaps between scientific inquiry and practical applications, Pharmaceutical Sciences is dedicated to advancing pharmaceutical knowledge and promoting innovative practices that address significant health challenges.

DARU-Journal of Pharmaceutical Sciences

Bridging research and practice in pharmaceutical sciences.
Publisher: SPRINGER INT PUBL AGISSN: Frequency: 2 issues/year

DARU-Journal of Pharmaceutical Sciences is a leading peer-reviewed journal published by SPRINGER INT PUBL AG that focuses on the dynamic and rapidly evolving fields of pharmaceutical sciences, including drug discovery, pharmacology, and toxicology. With an impressive Q2 ranking in both Drug Discovery and Miscellaneous Medicine categories for 2023, this journal stands out as a vital resource for researchers, professionals, and students alike, offering a platform for significant contributions to the scientific community. Covering a comprehensive scope from 2000 to 2024 and indexed by Scopus, the journal ranks within the top percentile in its field, with a ranking of #66/313 in Pharmacology and #34/157 in Drug Discovery, reaffirming its impact and relevance. The journal promotes open access to foster widespread dissemination of knowledge in pharmaceutical sciences, ultimately aiming to bridge the gap between research and clinical applications. For those looking to stay at the forefront of pharmaceutical innovation, DARU represents an invaluable connection to the latest studies and breakthrough findings.

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Fostering collaboration in critical pharmaceutical research.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Welcome to the JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, a prestigious open access journal published by FRONTIERS MEDIA SA since 2008, dedicated to advancing research in the fields of pharmacy and pharmaceutical sciences. With its strong rooting in Canada, this journal has established itself within the academic community by consistently delivering high-quality studies and insights, as evidenced by its respectable Q2 ranking in both Medicine (miscellaneous) and Pharmaceutical Science categories for 2023, along with a notable 77th percentile ranking in Pharmaceutical Science on Scopus. Spanning over two decades of publication from 1998 to 2024, the journal focuses on critical research areas including pharmacology, toxicology, and drug development. By providing open access to its articles, the journal ensures that vital scientific information is readily available to researchers, professionals, and students alike, fostering collaboration and innovation within these essential disciplines. We invite you to explore the latest findings and contribute to the ongoing dialogue in pharmaceutical research through this essential platform.

Indian Journal of Pharmaceutical Education and Research

Connecting scholars to drive advancements in drug formulation.
Publisher: ASSOC PHARMACEUTICAL TEACHERS INDIAISSN: 0019-5464Frequency: 4 issues/year

Indian Journal of Pharmaceutical Education and Research, published by the Association of Pharmaceutical Teachers of India, is a pivotal platform for scholarly discussion in the field of pharmacology, toxicology, and pharmaceutics. ISSN 0019-5464, this esteemed journal aims to foster the exchange of innovative research, clinical advancements, and educational practices within the pharmaceutical sciences community. As a Q3-ranked journal in its category as of 2023, it reflects a commitment to upholding the standards of academic excellence and contributes significantly to the ongoing development of pharmaceutical education. The journal is a valuable resource for researchers, professionals, and students, with content spanning various key areas including drug formulation, safety, and the latest trends in pharmaceutical education. By providing open access to its research and reviews, the journal ensures that vital information is disseminated widely, promoting collaboration and learning among stakeholders in the pharmaceutical sector. Based in Bangalore, India, the journal has been instrumental in highlighting regional research while fostering a global dialogue in pharmaceutical sciences. As it continues its journey from 2008 to 2024, it remains dedicated to impacting the field through rigorous peer-reviewed content and engaging with contemporary challenges in healthcare and education.